Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

2.4.1.47: N-acylsphingosine galactosyltransferase

This is an abbreviated version!
For detailed information about N-acylsphingosine galactosyltransferase, go to the full flat file.

Word Map on EC 2.4.1.47

Reaction

UDP-alpha-D-galactose
+
a ceramide
=
UDP
+
a beta-D-galactosylceramide

Synonyms

ceramide galactosyltransferase, cerebroside synthase, CGalT, CGT, EC 2.4.1.45, galactosyltransferase, uridine diphosphogalactose-2-hydroxyacylsphingosine, galactosyltransferase, uridine diphosphogalactose-acylsphingosine, GALT, UDP galactose-N-acylsphingosine galactosyltransferase, UDPgalactose-2-hydroxyacylsphingosine galactosyltransferase, UDPgalactose:2-2-hydroxyacylsphingosine galactosyltransferase, UDPgalactose:ceramide galactosyltransferase, UGT8, uridine diphosphogalactose-2-hydroxyacylsphingosine galactosyltransferase, uridine diphosphogalactose-acylsphingosine galactosyltransferase

ECTree

     2 Transferases
         2.4 Glycosyltransferases
             2.4.1 Hexosyltransferases
                2.4.1.47 N-acylsphingosine galactosyltransferase

Inhibitors

Inhibitors on EC 2.4.1.47 - N-acylsphingosine galactosyltransferase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
Detergents
DL-sphingosine
Octanoyl-D-threo-p-nitro-1-phenyl-2-amino-1,3-propanediol
-
-
-
Phospholipase A
-
almost complete inactivation
-
Phospholipase C
-
56% loss of activity
-
Protein inhibitor
-
from brain, kidney, spleen and liver of rat and other animals
-
sodium deoxycholate
-
strong inhibition
sodium taurocholate
-
strong inhibition
sodium taurodeoxycholate
-
strong inhibition
zoledronate
optimal inhibitor of human ceramide galactosyltransferase, showing a favorable steric hindrance factor in contrast to other inhibitors or UDP-gal. It exhibits binding sites distributed homogeneously that can bind simultaneously
additional information
-
nutritional inadequacy during the active growth phase of the brain causes significantly diminished enzyme activity
-